Skip to content

Construction and application of a new evaluation system for asthenopia

Construction and application of a new evaluation system for asthenopia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110691
Enrollment
Unknown
Registered
2025-10-17
Start date
2024-01-17
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenopia

Interventions

Normal adult group:Humidity 60%+ no wind
Humidity 40%+ light breeze
Group of patients with video terminal asthenopia syndrome:Humidity 60%+ no wind
Control group:Placebo of Zhangyanming tablets

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-55 years old; 2. Binocular best corrected visual acuity <= 0.0 logMAR; 3. In accordance with the diagnostic criteria of video terminal asthenopia syndrome of western medicine and liver and kidney deficiency of traditional Chinese medicine; 4. Reading or watching delicate work cannot last for 45 minutes; 5. Be cooperative with investigators. (Normal adults need to meet 1, 2, 5 items, patients with video terminal asthenopia syndrome need to meet all the above 5 items)

Exclusion criteria

Exclusion criteria: 1. Subjects with uncorrected refractive error; 2. Strabismus, glaucoma, severe dry eye disease; 3. Active eye diseases other than asthenopia (such as uveitis, eye infection, etc.); 4. Pregnant, lactating women, and mentally ill subjects; 5. Complicated with serious systemic diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; 6. Allergic constitution or known to be allergic to the test drug; 7. Participating in other drug clinical trials or research trials at the same time; 8. Not cooperating with investigators.

Design outcomes

Primary

MeasureTime frame
Critical flicker frequency;Quick contrast sensitivity function;Blinking frequency;

Secondary

MeasureTime frame
Asthenopia score;Quantitative scoring of TCM syndromes;

Countries

China

Contacts

Public ContactJiawei Zhou

The Eye Hospital of Wenzhou Medical University

zhoujw@mail.eye.ac.cn+86 138 6613 5735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026